Farida Bakr Mohamed
Cairo, Egypt
NCT Number: NCT06766955
The purpose of the study is to find out the prevalence of lower cross syndrome among female college students and its relation with dysmenorrhea.
Trial opening soon.
Get Notified18 year–25 year
Female
Observational
Cairo, Egypt
In individuals with lower cross syndrome (LCS), there is often a notable tightness in the hip flexors and the lower back musculature, which is typically accompanied by a corresponding weakness in the abdominal muscles and the gluteus maximus. This imbalance is not merely a matter of discomfort; it fundamentally disrupts the normal distribution of biomechanical forces within the lower back. When the muscles that support the pelvis and spine are not functioning optimally, it can lead to altered movement patterns and increased strain on the lumbar region.
The positioning of the uterus can also be adversely affected by this muscular imbalance. Anterior or posterior displacement of the uterus can occur as a result of the altered pelvic alignment associated with LCS. This displacement can create additional tension within the surrounding soft tissues and muscles, leading to a cascade of physiological responses.
One notable consequence of this tension is the excessive secretion of prostaglandins, which are hormone-like substances that play a key role in the regulation of inflammation and pain. Elevated levels of prostaglandins are often linked to dysmenorrhea, or painful menstruation, which can further exacerbate discomfort and impact the daily lives of those affected.
To date, there is only one previous study in India investigating the prevalence of LCS among female college students and its relation with dysmenorrhea. There is lack of literature evidence, which can show the prevalence of LCS among female college students in Egypt. So, this study aims to fill a critical gap in existing literature by providing valuable insights into the prevalence and associated factors of LCS in this population in Egypt.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 weeks
The Thomas test is used to assess the hip flexion Tightness. Position: The measurement of iliopsoas muscle length involved the subject lying supine on a plinth with one thigh protruding while the examiner checks for excessive lordosis. The non-tested hip is flexed and held close to the chest to stabilize the pelvis and flatten the lumbar spine. Using a universal goniometer, the examiner measures the iliopsoas length on the opposite side. The fulcrum is placed above the greater trochanter, the movable arm parallel to the femoral shaft, and the stationary arm parallel to the plinth. If the hip flexion angle exceeds 15 degrees, the patient's straight leg rises off the table and a muscle stretch end feel will be felt, the iliopsoas is considered tight.
Time frame: 6 weeks
The length of the spinal extensor muscles will be measured by modified Schober test while a female college student standing and her back facing the examiner. A reference line is marked at the intersection of the Venus dimples (Posterior superior iliac spine PSIS) on her lower back, with additional lines drawn 10 cm above and 5 cm below this point. The student then bends forward, and the examiner measured the increase in distance between these points using a measuring tape. The outcome measure is calculated by determining the differences between these points
Time frame: 6 weeks
In this procedure, females are placed in a supine position with different arm placements based on the grade. The examiner stands beside the table at the chest level to ensure the scapula clears the table. The patient is asked to assume the end position by flexing their trunks fully, curling up until the scapula is off the table. They were guided with the instruction, "Tuck your chin and lift your head, shoulders, and arms off the table, as if doing a sit-up and hold it." (Magee, 2002).
The gradings of this test are:
Normal 5= Hands behind neck, until scapulae clear table 20-30sec hold. Good 4= Arms crossed over chest, until scapulae clear table 15-20sec hold. Fair 3= Arms straight, until scapulae clear table 10-15 sec held. Poor 2= Arms extended, towards knees, until top of scapulae lift from table 1-10 sec hold.
Trace 1= Unable to raise more than head off table.
Time frame: 6 weeks
The subject is placed in prone with the hips straight and the knee flexed to 90 degrees. The student is asked to extend the hip, keeping the knee flexed. Anterior force is applied to the posterior thigh. The pelvis is stabilized during the movement. Both legs are tested.
The grading of this test are:
Normal 5 = indicates that the individual achieves complete hip extension and can maintain the end position against maximal resistance.
Good 4 = signifies that hip extension is achievable and can be sustained against heavy to moderate resistance.
Fair 3 = denotes the ability to complete full hip extension and maintain the end position, although no resistance is applied.
Poor 2 = reflects the capacity to perform the full range of hip extension while in a side-lying position.
Trace 1 = is characterized by palpable contractions of the gluteus maximus, which manifest as a narrowing of the gluteal crease, without any observable movement at the joint.
Time frame: 6 weeks
The Menstrual Distress Questionnaire (MEDI-Q) includes 25 items that cover symptoms related to menstruation, such as pain, discomfort, psychological or cognitive changes, and gastrointestinal issues. It evaluates the impact of these symptoms on daily functioning and quality of life during the menstrual phase and compares their frequency to the intermenstrual and premenstrual phases. The MEDI-Q provides scores for specific symptoms and four overall indices for a comprehensive assessment of menstrual distress. The MEDI-Q is a valid and reliable tool for assessing menstrual distress and its impact on psychological well-being. The items include subtitles ranging from 0 to 3. The total score ranges from 0 to 125. Lower score indicates lower menstrual symptoms and vice versa.
Contact information is provided by the study sponsor or research team.
Amira Nagy, PHD
CONTACT
Farida B Mohamed, Master
CONTACT
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06739889
Cross Syndrome, Oculocerebral hypopigmentation syndrome type Preus
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT04668040
Cross Syndrome, Oculocerebral hypopigmentation syndrome type Preus
Peshawar, KPK, Pakistan
View Trial DetailsNCT07702604
Neck Pain, Neurologic Manifestations
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07698392
Oculocerebral hypopigmentation syndrome type Preus, Upper Cross Syndrome
Cairo, Cairo Governorate, Egypt
View Trial Details